Two drugs widely used to treat adults with heart failure—furosemide and torsemide—showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported ...
Jan 17, 2023
0
51
Researchers from the Medway School of Pharmacy (MSOP)—a partnership between the universities of Kent and Greenwich—in collaboration with colleagues from Inselspital (University Hospital of Bern, Switzerland) and the University ...
Jan 12, 2023
0
14
Survival rates for children and adolescents with melanomas are high, according to a study published online Dec. 9 in the Journal of the American Academy of Dermatology.
Jan 11, 2023
0
10
The transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much as possible soon after diagnosis, according to the results of a study led by UC San Francisco.
Jan 4, 2023
0
23
Progression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according to a study published ...
Jan 3, 2023
0
7
Patients with congenital heart diseases often suffer from obstructions in the right ventricular outflow tract (RVOT), which carries blood from the heart to the lungs. These obstructions can be repaired with surgical procedures. ...
Jan 3, 2023
0
10
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of efficacy in a small pilot trial involving patients with lymphoma of the brain and/or spinal cord, Dana-Farber Cancer Institute ...
Dec 11, 2022
0
38
Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer, according to updated ...
Dec 7, 2022
0
23
Michael Dismorr at the research group Thoracic Surgery, the Department of Molecular Medicine and Surgery, defended his thesis "Epidemiological studies of bioprosthetic aortic valves" on November 18, 2022.
Nov 28, 2022
0
2
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...
Nov 23, 2022
0
64
